Average Co-Inventor Count = 6.40
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Hoffmann-la Roche Inc. (24 from 4,942 patents)
2. F. Hoffmann-la Roche Ag (168 patents)
24 patents:
1. 12421229 - Hydropyrido[1,2-α]pyrazine compounds for the treatment of autoimmune disease
2. 12421252 - Spiro (isobenzofuranazetidine) compounds for the treatment of autoimmune disease
3. 12351575 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
4. 12247036 - Tricyclic compounds for the treatment of cancer
5. 12060333 - Aminocarbamoyl compounds for the treatment of viral infections
6. 11713327 - Heteroaryl heterocyclyl compounds for the treatment of autoimmune disease
7. 11046671 - Dihydropyrimidinyl benzazepine carboxamide compounds
8. 10590112 - Dihydropyrimidinyl benzazepine carboxamide compounds
9. 10544102 - Benzazepine dicarboxamide compounds with secondary amide function
10. 10428069 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
11. 10428027 - Sulfinylphenyl or sulfonimidoylphenyl benzazepines
12. 10370338 - Benzazepine dicarboxamide compounds with tertiary amide function
13. 10189838 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection
14. 10081627 - 6-fused heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infection
15. 9890155 - Aza-oxo-indoles for the treatment and prophylaxis of respiratory syncytial virus infection